jueves, 25 de agosto de 2022

Pfizer and BioNTech seek emergency use authorization for Omicron BA.4/5-adapted booster vaccine

Pfizer and BioNTech seek emergency use authorization for Omicron BA.4/5-adapted booster vaccine

No hay comentarios: